One of the most widely used is the Memorial Sloan Kettering Cancer Center (MSKCC) colon cancer recurrence nomogram, which predicts freedom from recurrence based on nine clinicopathological features including age, tumor size, preoperative carcinoembryonic antigen (CEA), use of adjuvant chemotherapy, and other indicators of tumor invasiveness [6]. The gene discussed is CEACAM5; the disease is colonic neoplasm.